Edition:
United States

Shenzhen Salubris Pharmaceuticals Co Ltd (002294.SZ)

002294.SZ on Shenzhen Stock Exchange

37.10CNY
17 Nov 2017
Change (% chg)

¥-1.18 (-3.08%)
Prev Close
¥38.28
Open
¥38.00
Day's High
¥38.66
Day's Low
¥37.00
Volume
6,803,749
Avg. Vol
5,570,024
52-wk High
¥39.45
52-wk Low
¥27.90

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.38 December 18 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 2
(2) OUTPERFORM 6 7 7 7
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 1.90

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 1,060.28 1,060.28 1,060.28 1,293.21
Quarter Ending Mar-18 1 927.91 927.91 927.91 1,129.17
Year Ending Dec-17 8 4,233.88 4,278.27 4,159.87 4,647.53
Year Ending Dec-18 8 4,769.18 4,987.83 4,587.04 5,394.96
Earnings (per share)
Quarter Ending Dec-17 1 0.38 0.38 0.38 0.46
Quarter Ending Mar-18 1 0.33 0.33 0.33 0.41
Year Ending Dec-17 8 1.44 1.55 1.40 1.67
Year Ending Dec-18 8 1.67 1.87 1.60 1.96
LT Growth Rate (%) 1 18.60 18.60 18.60 19.04

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1,063.84 1,067.39 3.56 0.33
Quarter Ending Jun-17 1,070.63 1,062.47 8.16 0.76
Quarter Ending Mar-17 954.96 972.21 17.25 1.81
Quarter Ending Dec-16 1,099.45 1,004.20 95.25 8.66
Quarter Ending Sep-16 1,099.45 937.52 161.94 14.73

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1,060.28 1,060.28 1,063.84 1,063.84 1,293.21
Quarter Ending Mar-18 927.91 927.91 927.91 927.91 1,129.17
Year Ending Dec-17 4,233.88 4,233.88 4,232.37 4,248.42 4,647.53
Year Ending Dec-18 4,769.18 4,769.18 4,773.28 4,772.25 5,394.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 1 1
Year Ending Dec-18 0 0 1 1
Earnings